242 related articles for article (PubMed ID: 33260723)
41. Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice.
Correa-Netto NF; Coelho LS; Galfano GS; Nishide F; Tamura F; Shimizu MK; Santos JG; Linardi A
Braz J Med Biol Res; 2017 Jun; 50(7):e6037. PubMed ID: 28591380
[TBL] [Abstract][Full Text] [Related]
42. The pharmacological interaction of compounds in ayahuasca: a systematic review.
Ruffell S; Netzband N; Bird C; Young AH; Juruena MF
Braz J Psychiatry; 2020; 42(6):646-656. PubMed ID: 32638916
[TBL] [Abstract][Full Text] [Related]
43. Components of
Santos BWL; Moreira DC; Borges TKDS; Caldas ED
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458698
[No Abstract] [Full Text] [Related]
44. Ayahuasca: Uses, Phytochemical and Biological Activities.
Estrella-Parra EA; Almanza-Pérez JC; Alarcón-Aguilar FJ
Nat Prod Bioprospect; 2019 Aug; 9(4):251-265. PubMed ID: 31134518
[TBL] [Abstract][Full Text] [Related]
45. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking.
Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG
Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062
[TBL] [Abstract][Full Text] [Related]
46. The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.
Morales-García JA; de la Fuente Revenga M; Alonso-Gil S; Rodríguez-Franco MI; Feilding A; Perez-Castillo A; Riba J
Sci Rep; 2017 Jul; 7(1):5309. PubMed ID: 28706205
[TBL] [Abstract][Full Text] [Related]
47. Biodiversity of β-Carboline Profile of
Santos BWL; Oliveira RC; Sonsin-Oliveira J; Fagg CW; Barbosa JBF; Caldas ED
Plants (Basel); 2020 Jul; 9(7):. PubMed ID: 32660098
[TBL] [Abstract][Full Text] [Related]
48. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.
McIlhenny EH; Riba J; Barbanoj MJ; Strassman R; Barker SA
Biomed Chromatogr; 2011 Sep; 25(9):970-84. PubMed ID: 21058415
[TBL] [Abstract][Full Text] [Related]
49. Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties.
Politi M; Tresca G; Menghini L; Ferrante C
Planta Med; 2022 Nov; 88(14):1275-1286. PubMed ID: 34794194
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans.
Valle M; Maqueda AE; Rabella M; Rodríguez-Pujadas A; Antonijoan RM; Romero S; Alonso JF; Mañanas MÀ; Barker S; Friedlander P; Feilding A; Riba J
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1161-75. PubMed ID: 27039035
[TBL] [Abstract][Full Text] [Related]
51. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
Freedland CS; Mansbach RS
Drug Alcohol Depend; 1999 May; 54(3):183-94. PubMed ID: 10372792
[TBL] [Abstract][Full Text] [Related]
52. Health status of ayahuasca users.
Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
[TBL] [Abstract][Full Text] [Related]
53. Exposure to ayahuasca induces developmental and behavioral alterations on early life stages of zebrafish.
Andrade TS; de Oliveira R; da Silva ML; Von Zuben MV; Grisolia CK; Domingues I; Caldas ED; Pic-Taylor A
Chem Biol Interact; 2018 Sep; 293():133-140. PubMed ID: 30086270
[TBL] [Abstract][Full Text] [Related]
54. An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.
Correa-Netto NF; Masukawa MY; Nishide F; Galfano GS; Tamura F; Shimizo MK; Marcato MP; Santos JG; Linardi A
Braz J Med Biol Res; 2017 Jun; 50(7):e6036. PubMed ID: 28591379
[TBL] [Abstract][Full Text] [Related]
55. Harmala Alkaloids Identify Ayahausca Intoxication in a Urine Drug Screen.
Pope JD; Choy KW; Drummer OH; Schneider HG
J Anal Toxicol; 2019 May; 43(4):e23-e27. PubMed ID: 30566569
[TBL] [Abstract][Full Text] [Related]
56. Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis.
Callaway JC; Brito GS; Neves ES
J Psychoactive Drugs; 2005 Jun; 37(2):145-50. PubMed ID: 16149327
[TBL] [Abstract][Full Text] [Related]
57. A rapid analytical strategy for the determination of ayahuasca alkaloids in non-ritualistic approaches by UHPLC-MS/MS.
Eller S; Borges GR; Ossanes DS; Birk L; Scheid C; Yonamine M; Grossi P; Merib JO; Oliveira TF
Forensic Sci Int; 2020 Jul; 312():110298. PubMed ID: 32387868
[TBL] [Abstract][Full Text] [Related]
58. Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment.
Cata-Preta EG; Serra YA; Moreira-Junior EDC; Reis HS; Kisaki ND; Libarino-Santos M; Silva RRR; Barros-Santos T; Santos LC; Barbosa PCR; Costa JL; Oliveira-Lima AJ; Berro LF; Marinho EAV
Front Pharmacol; 2018; 9():561. PubMed ID: 29896106
[TBL] [Abstract][Full Text] [Related]
59. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna DJ
Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
[TBL] [Abstract][Full Text] [Related]
60. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.
dos Santos RG
J Psychoactive Drugs; 2013; 45(1):68-78. PubMed ID: 23662333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
